Comparison of dexmedetomidine administration on quality of early recovery after surgery

Dexmedetomidine: comparison of a single bolus administration with intraoperative continuous infusion on quality of early recovery after surgery

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

CRIS

Registry ID

KCT0001992

Enrollment

120

Registered

2016-08-01

Start date

2016-08-01

Completion date

Unknown

Last updated

2019-03-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Drug : Study drug I: [dexmedetomidine 200 microgram/2 mL + Normal saline 38 mL = 200 micrgram/40 mL] or normal saline with the same volume Stuuy drug II: [dexmedetomidine 0. 5 mL (50 microgram) + Norm

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Adult patients, aged 19-64 years, classified as American Society of Anesthesiologists (ASA) physical status I or II, and scheduled for laparoscopy-assisted distal gastrectomy under general anesthesia

Exclusion criteria

Exclusion criteria: : a history of allergy to any study medications : impairment of hepatic or renal function : psychiatric or central nervous system disturbance that would preclude completion of QoR-40 questionnaire : use of steroid, antiemetics, analgesics, or antipsychotic drugs within 1 week of surgery

Design outcomes

Primary

Measure	Time frame
Quality of recovery 40 (QoR-40) Survey score;Recovery time (time to the first ambulation, oral intake, and flatus)	—

Secondary

Measure	Time frame
Verbal numeric rating pain score;Cumalative consumption of intravenous pain control (IV PCA)	—

Countries

Korea, Republic of

Contacts

Public ContactDuk Kyung Kim

Samsung Medical Center

dikei@hanmail.net+82-2-3410-0343

Outcome results